Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/37508
Title: Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model
Authors: Takaseya, Tohru
Fumoto, Hideyuki
Saraiva, Roberto M.
Shiose, Akira
Arakawa, Yoko
Park, Margaret
Rao, Santosh
Dessoffy, Raymond
Kramer, Larry D.
Juravic, Mark
Lombardi, Pierluca
Fukamachi, Kiyotaka
Affilliation: Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Cleveland Clinic. Heart and Vascular Institute. Department of Cardiovascular Medicine. Cleveland, OH, USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Cleveland Clinic. Heart and Vascular Institute. Department of Cardiovascular Medicine. Cleveland, OH, USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
MAQUET Cardiovascular LLC. San Jose, CA USA.
MAQUET Cardiovascular LLC. San Jose, CA USA.
Cleveland Clinic. Lerner Research Institute. Department of Biomedical Engineering. Cleveland, OH, USA.
Abstract: Objective: The purpose of this study was to evaluate the implantability of a novel epicardial mitral annuloplasty device and its ability to reduce the septal-lateral (S-L) dimension of the mitral annulus. Methods: The devices were implanted on the beating heart in 2 healthy dogs (the 24-mm long device in dog A and the 27-mm and 24-mm standard devices in dog B) by sliding the anterior arm onto the floor of the transverse sinus and positioning the posterior arm just apical to the atrioventricular groove on the left ventricular posterolateral wall. The devices were secured with titanium helical tacks driven through the device into the ventricular wall. Twodimensional epicardial echocardiograms were performed before and after device implantation to evaluate the degree of mitral regurgitation (MR) and the S-L dimension. Results: Device implantation was uneventful, taking only ~30 seconds to deploy. MR (1) in both dogs at baseline was reduced to zero after implant. The reductions in S-L dimension in systole for the 24-mm device were 7.5% in dog A and 30.5% in dog B. For the 27-mm device in dog B, S-L reduction in systole was 29.9%. The leaflet coaptation length was increased in both cases. Conclusions: The new device was effective in reducing S-L dimension and 1 MR without requiring the use of cardiopulmonary bypass. We are currently evaluating this device for the treatment of MR in a rapid-pacing canine heart failure model.
Keywords: Mitral valve repair
Minimally invasive surgery
Off-pump surgery
Issue Date: 2010
Publisher: Lippincott, Williams & Wilkins
Citation: TAKASEYA, Tohru et al. Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model. Innovations, v. 5, n. 1, p. 28-32, Jan./Feb. 2010.
Description: Roberto M. Saraiva. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
DOI: 10.1097/imi.0b013e3181cdf735
ISSN: 1556-9845
Copyright: restricted access
Appears in Collections:INI - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
ve_Takaseya_Tohru_etal_INI_2010.pdf884.01 kBAdobe PDF    Request a copy



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.